What does CUSIP 405024100 represent in this 13F holders report?

CUSIP 405024100 is the security identifier for HAE - HAEMONETICS CORP - Common stock, $.01 par value per share used to aggregate holder disclosures.

How many institutions held HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in Q3 2023?

294 institutional investors reported HAE - HAEMONETICS CORP - Common stock, $.01 par value per share for Q3 2023. Use the holders table for investor-level position and value details.

HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)

CUSIP: 405024100

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common stock, $.01 par value per share
Shares outstanding: 46,498,422
Total 13F shares: 50,792,206
Share change: +202,598
Total reported value: $4,551,407,114
Put/Call ratio: 12%
Price per share: $89.58
Number of holders: 294
Value change: +$20,351,169
Number of buys: 131
Number of sells: 154

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 405024100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HAE - HAEMONETICS CORP - Common stock, $.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	14%	6,689,539	$569,547,350	—	30 Jun 2023	13F
BlackRock Finance, Inc.	13F	Company	13%	5,814,410	$495,038,867	—	30 Jun 2023	13F
VANGUARD GROUP INC	13F	Company	12%	5,353,712	$455,815,039	—	30 Jun 2023	13F
Neuberger Berman Group LLC	13F	Company	7.7%	3,572,871	$304,183,677	—	30 Jun 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	6.9%	3,216,912	$273,887,888	—	30 Jun 2023	13F
FMR LLC	13F	Company	4.4%	2,036,291	$173,369,816	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	3.8%	1,753,833	$149,321,342	—	30 Jun 2023	13F
FRANKLIN RESOURCES INC	13F	Company	3.5%	1,638,438	$139,496,607	—	30 Jun 2023	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	2.1%	996,208	$84,817,149	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.1%	991,418	$84,409,356	—	30 Jun 2023	13F
ROYCE & ASSOCIATES LP	13F	Company	1.9%	906,292	$77,161,701	—	30 Jun 2023	13F
Fisher Asset Management, LLC	13F	Company	1.9%	902,744	$76,859,624	—	30 Jun 2023	13F
Invesco Ltd.	13F	Company	1.7%	780,193	$66,425,632	—	30 Jun 2023	13F
Boston Partners	13F	Company	1.6%	759,592	$65,136,021	—	30 Jun 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.5%	702,659	$59,824,424	—	30 Jun 2023	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	1.4%	671,185	$57,145,000	—	30 Jun 2023	13F
Boston Trust Walden Corp	13F	Company	1.4%	668,860	$56,946,740	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	1.4%	649,138	$55,267,609	—	30 Jun 2023	13F
Bank of New York Mellon Corp	13F	Company	1.1%	534,627	$45,518,108	—	30 Jun 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.1%	521,489	$44,400,000	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	1.1%	516,132	$43,943,478	—	30 Jun 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.1%	492,499	$41,931,365	—	30 Jun 2023	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.88%	408,819	$34,806,850	—	30 Jun 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.83%	388,039	$33,037,641	—	30 Jun 2023	13F
Aristotle Capital Boston, LLC	13F	Company	0.67%	312,996	$26,648,447	—	30 Jun 2023	13F
HEARTLAND ADVISORS INC	13F	Company	0.61%	282,667	$24,066,268	—	30 Jun 2023	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.56%	261,815	$22,290,929	—	30 Jun 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.54%	250,555	$21,332,253	—	30 Jun 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.51%	238,231	$20,282,987	—	30 Jun 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.48%	224,002	$19,071,530	—	30 Jun 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.45%	207,081	$17,630,876	—	30 Jun 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.44%	205,956	$17,535,094	—	30 Jun 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.43%	198,516	$16,901,653	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.42%	195,842	$16,673,988	—	30 Jun 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.4%	187,678	$15,978,905	—	30 Jun 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.4%	183,738	$15,644,000	—	30 Jun 2023	13F
Retirement Systems of Alabama	13F	Company	0.39%	180,413	$15,360,363	—	30 Jun 2023	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.39%	179,863	$15,313,541	—	30 Jun 2023	13F
NORGES BANK	13F	Company	0.38%	178,890	$15,230,695	—	30 Jun 2023	13F
CITIGROUP INC	13F	Company	0.38%	178,618	$15,207,536	—	30 Jun 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.38%	177,957	$15,151,259	—	30 Jun 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.38%	177,460	$15,108,944	—	30 Jun 2023	13F
EMERALD ADVISERS, LLC	13F	Company	0.38%	174,850	$14,886,729	—	30 Jun 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.35%	161,815	$13,776,929	—	30 Jun 2023	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.34%	159,494	$13,579,320	—	30 Jun 2023	13F
SCHWARTZ INVESTMENT COUNSEL INC	13F	Company	0.34%	159,000	$13,537,260	—	30 Jun 2023	13F
LONDON CO OF VIRGINIA	13F	Company	0.34%	155,820	$13,266,493	—	30 Jun 2023	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.31%	142,502	$12,132,620	—	30 Jun 2023	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.29%	135,822	$11,563,885	—	30 Jun 2023	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.28%	127,878	$10,922,060	—	30 Jun 2023	13F

Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q3 2023

As of 30 Sep 2023, HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by 294 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,792,206 shares. The largest 10 holders included Capital Research Global Investors, BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, FRANKLIN RESOURCES INC, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, and ROYCE & ASSOCIATES LP. This page lists 294 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

288

Q3 2023 holders

294

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.